Diagnosing GIST Preoperatively: Challenges and Advantages
Various studies have analyzed how to better diagnose gastrointestinal stromal tumors at the preoperative stage.
Various studies have analyzed how to better diagnose gastrointestinal stromal tumors at the preoperative stage.
We explore how imatinib became the first-line therapy for metastatic GIST, and whether it should be discontinued in some circumstances.
We discuss current therapeutic strategies in targeting the PDGF/PDGFR signaling pathway in cancer research.
We describe the numerous benefits that laparoscopic surgery confers to patients with GIST, compared to open surgery.
We explore a Chinese study on adherence to imatinib among GIST patients and how patient adherence can be improved in general.
Yamagachi and colleagues described a rare case report of a female patient with a gastrointestinal stromal tumor with ovarian metastasis.
We explore the impact of imatinib on outcomes of patients with gastrointestinal stromal tumors, as well as ways to prevent resistance to it.
As we look over the evolution of medicine, we see we have gone from what can be described as crude experimentation in ancient times to more sophisticated ways of managing the signs and symptoms of a disease in the past century. The effort to dig deeper through the layers of a disease to reach its…
The challenge for scientists is to develop immunotherapies targeting new molecular sites that can provide consistent clinical benefits in GIST patients.
The clinical management of metastatic gastrointestinal stromal tumor (GIST) has greatly improved since the early 2000s.